All National Institute for Health and Care Excellence (NICE) articles
-
Industry newsPatient groups get pharma funding; often petition NICE
An investigation by The Observer reveals how patient groups receiving funding from pharma often petition NICE for NHS approvals.
-
Industry newsNICE recommends its first-ever oral migraine treatment
Rimegapant – has been approved for use in the NHS giving a treatment option for people who have failed with different drug options.
-
Industry newsMHRA plans medical device technologies streamlined pathway
UK agency aims to make route-to-market much more straightforward for manufacturers with Innovative Devices Access Pathway.